NUZ 0.00% 23.0¢ neurizon therapeutics limited

Ann: Stable Patient in MND trial reaches 6-months on MPL, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 383 Posts.
    lightbulb Created with Sketch. 66
    Great news tend to agree Cohort 2 could be the sweet spot hopefully there are a number of patents showing stable disease. if so anything could happen on the upside.
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.